Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
International Business is expected to register double-digit growth in constant currency terms
Aurigene.AI is an end-to-end solution for small molecule drug discovery
These facilities are commissioned by Aurobindo's wholly own subsidiary: Lyfius Pharma Private Limited, Qule Pharma Private Limited, Eugia Steriles Private Limited and Auroactive Pharma Private Limited.
The company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
The facility will manufacture tablets, capsules, and injections for the oncology segment
Subscribe To Our Newsletter & Stay Updated
